<qa>  At least 4 weeks since prior flutamide therapy 6 weeks for bicalutamide- At least 4 weeks since prior flutamide therapy 6 weeks for bicalutamide or nilutamide with continued evidence of progressive disease documented by at least 1 PSA value after discontinuation 